drugset

drugset / Trial / NCT00141388

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures

NCT00141388 ↗

Phase 3 Completed 455 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the long-term safety and efficacy of pregabalin in patients with partial seizures.

Timeline

Start: 1998-07
Primary completion: —
Completion: 2005-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pregabalin	Small molecule	—	—

Indications